A causal role for hyperinsulinemia in obesity

Area of Science:

• Metabolic research
• Endocrinology
• Obesity research

Background:

• Insulin plays a key role in regulating lipid metabolism, influencing uptake, lipolysis, and lipogenesis.
• Elevated insulin levels are frequently observed in obesity, and interventions reducing insulin have shown potential for weight loss.
• The direct causal link between insulin hypersecretion and obesity development in mammals has been debated due to a lack of definitive loss-of-function studies.

Purpose of the Study:

• To investigate the causal role of insulin hypersecretion in obesity development.
• To evaluate the effects of reduced circulating insulin on body weight and metabolic homeostasis.
• To re-evaluate current understanding of obesity, insulin resistance, and diabetes.

Main Methods:

• Discussion of theoretical considerations regarding insulin's role in obesity.
• Analysis of studies using genetically modified mice resistant to diet-induced hyperinsulinemia.
• Review of evidence from long-term studies on the effects of modest insulin reduction.

Main Results:

• Genetic models demonstrate that preventing hyperinsulinemia protects against diet-induced obesity.
• Modest reductions in circulating insulin levels effectively prevent weight gain, with lasting effects.
• Crucially, these reductions in insulin do not impair glucose homeostasis.
• Body weight and lipid homeostasis are more sensitive to insulin level changes than glucose homeostasis.

Conclusions:

• Evidence from genetic loss-of-function models necessitates a re-evaluation of established paradigms in obesity, insulin resistance, and diabetes.
• Findings suggest that targeting insulin levels may be a viable strategy for managing obesity.
• The potential clinical translation of these findings to human obesity treatment warrants further investigation.